[Cancers of the stomach and peritoneal carcinoses: will hyperthermia be a new therapeutic approach?].
Overall survival rate of gastric adenocarcinoma is poor whatever the therapeutic is. Main reasons for this poor prognosis are regional failure and local recurrences. Using hyperthermia could be of interest in peritoneal carcinomatosis during gastric carcinoma: in vitro cytotoxic effect of hyperthermia is well known. Using hyperthermia in combination with intra peritoneal chemotherapy could improve local control. Preliminary results of pilot studies treating peritoneal carcinomatosis with intra peritoneal chemohyperthermia are reported.
Gilly
F N
FN
Service de Chirurgie Générale et Thoracique, Centre Hospitalier Lyon Sud.
Carry
P Y
PY
Sayag
A C
AC
Panteix
G G
GG
Bienvenu
J
J
Brachet
A
A
Salle
B
B
Braillon
G
G
D000970:Antineoplastic Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005743:Gastrectomy; D006801:Humans; D006979:Hyperthermia, Induced / Q000009:adverse effects / Q000379:methods* / Q000639:trends; D010534:Peritoneal Neoplasms / Q000188:drug therapy / Q000556:secondary / Q000628:therapy*; D013274:Stomach Neoplasms / Q000473:pathology / Q000628:therapy*
D000970:Antineoplastic Agents
Cancers de l'estomac avec carcinoses péritonéales: l'hyperthermie sera-t-elle une nouvelle voie thérapeutique?